Who are Polyethylene glycol and bisacodyl's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): polyethylene glycol +Bisacodyl.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polyethylene-glycol-and-bisacodyl.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Polyethylene glycol and bisacodyl — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polyethylene glycol and bisacodyl (Polyethylene glycol and bisacodyl) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination laxative (osmotic + stimulant). Area: Gastroenterology.

marketed Combination laxative (osmotic + stimulant) Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Polyethylene glycol and bisacodyl (Polyethylene glycol and bisacodyl) — Taipei Medical University WanFang Hospital. Polyethylene glycol acts as an osmotic laxative to draw water into the bowel, while bisacodyl stimulates colonic muscle contractions to promote bowel evacuation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Polyethylene glycol and bisacodyl TARGET	Polyethylene glycol and bisacodyl	Taipei Medical University WanFang Hospital	marketed	Combination laxative (osmotic + stimulant)
polyethylene glycol +Bisacodyl	polyethylene glycol +Bisacodyl	Medical University of Warsaw	marketed	Combination laxative (osmotic + stimulant)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination laxative (osmotic + stimulant) class)

Medical University of Warsaw · 1 drug in this class
Taipei Medical University WanFang Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Polyethylene glycol and bisacodyl — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-and-bisacodyl. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab